Home › NDC Lookup › RxCUI directory › RxCUI 1925498

Dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet — RxCUI 1925498

RxNorm drug concept · Semantic clinical drug
RxCUI 1925498 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1925498
Official nameDapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdapagliflozin 10 MG (as dapagliflozin propanediol 12.3 MG) / saxagliptin 5 MG (as saxagliptin HCl 5.95 MG) Oral Tablet
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Saxagliptin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Saxagliptin works by blocking an enzyme called DPP-4, which normally destroys helpful hormones your gut releases after eating. By blocking that enzyme, saxagliptin lets those hormo...
  • What exactly does saxagliptin do — and how is it different from other diabetes pills?
  • You can take saxagliptin with or without food — whichever works best for your routine. A meal does slightly slow down how quickly it's absorbed, but it doesn't meaningfully change...
  • Can I take this pill with food, or do I need to take it on an empty stomach?
📖 Read our full Saxagliptin guide →

🕸️ Concept Web — How Dapagliflozin 10 MG / saxagliptin 5 MG Oral Tabl... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet RxCUI 1925498

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Dapagliflozin 1488564
    • Saxagliptin 857974
    • Dapagliflozin / saxagliptin 1727500
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Qtern 1925499
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dapagliflozin / saxagliptin Oral Tablet 1925497
    • Dapagliflozin / saxagliptin Oral Product 1925495
    • Dapagliflozin / saxagliptin Pill 1925496
    • Dapagliflozin / saxagliptin Oral Tablet [Qtern] 1925501
    • Qtern Oral Product 1925502
    • Qtern Pill 1925503
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Dapagliflozin 10 MG 1488565
    • Saxagliptin 5 MG 858034
    • Dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet [Qtern] 1925504
    • Dapagliflozin 10 MG / saxagliptin 5 MG [Qtern] 1925500

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dapagliflozin 10 MG SCDC · 1488565
  • Saxagliptin 5 MG SCDC · 858034
  • Dapagliflozin / saxagliptin Oral Tablet SCDF · 1925497
  • Dapagliflozin / saxagliptin Oral Product SCDG · 1925495
  • Dapagliflozin / saxagliptin Pill SCDG · 1925496

Brand-Name Concepts

  • Dapagliflozin 10 MG / saxagliptin 5 MG Oral Tablet [Qtern] SBD · 1925504
  • Dapagliflozin 10 MG / saxagliptin 5 MG [Qtern] SBDC · 1925500
  • Dapagliflozin / saxagliptin Oral Tablet [Qtern] SBDF · 1925501
  • Qtern Oral Product SBDG · 1925502
  • Qtern Pill SBDG · 1925503
  • Qtern BN · 1925499

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1925498 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72205-0438-01 30 TABLET, FILM COATED in 1 BOTTLE (72205-438-01) DAPAGLIFLOZIN AND SAXAGLIPTIN Novadoz Pharmaceuticals LLC 2026-04-09
72205-0438-02 90 TABLET, FILM COATED in 1 BOTTLE (72205-438-02) DAPAGLIFLOZIN AND SAXAGLIPTIN Novadoz Pharmaceuticals LLC 2026-04-09
Observed labelers: Novadoz Pharmaceuticals LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.